cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.14791945
title: Global Carded Packaging Market 2025 To 2034

description: Carded Packaging Market Size, Trends and Insights By Product Type (Clamshells, Trapped Cardeds, Face Seal Cardeds, Carded Cards), By Technology (Thermoforming, Cold Forming), By Material Type (Plastic, Paper & Paperboard, Aluminum), By Application (Consumer Goods, Pharmaceuticals, Electronics & Semiconductors, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034.

Reports Description

Global Carded Packaging Market is estimated to be valued at USD 32.89 Billion in 2025 and is expected to reach USD 52.78 Billion by 2034, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2034.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=61869
DOI: 10.15468/dl.8n79t5
title: Occurrence Download

description: A dataset containing 3171 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Culex sitiens Wiedemann, 1828"
 ]
}

 The dataset includes 3171 records from 29 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009714-250127130748423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14791967
title: Global Ready-To-Eat Packaging Market 2025 To 2034

description: Ready-To-Eat Packaging Market Size, Trends and Insights By Material (Plastics, Paper and paperboard, Metal, Glass, Others), By Packaging Type (Rigid packaging, Flexible packaging, Semi-rigid packaging), By Product (Boxes and cartons, Cans, Cups and bowls, Films and wraps, Pouches, Trays, Others), By Application (Ready-to-eat meals, Instant noodles and pasta, Snacks and confectionery, Meat and seafood, Fruits and vegetables, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034.

Reports Description

Global Ready-to-Eat Food Market size is estimated at USD 428.80 Billion in 2025 and is expected to reach USD 546.08 Billion by 2034, at a CAGR of 5.14% during the forecast period.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=61876
DOI: 10.5281/zenodo.14791968
title: Global Ready-To-Eat Packaging Market 2025 To 2034

description: Ready-To-Eat Packaging Market Size, Trends and Insights By Material (Plastics, Paper and paperboard, Metal, Glass, Others), By Packaging Type (Rigid packaging, Flexible packaging, Semi-rigid packaging), By Product (Boxes and cartons, Cans, Cups and bowls, Films and wraps, Pouches, Trays, Others), By Application (Ready-to-eat meals, Instant noodles and pasta, Snacks and confectionery, Meat and seafood, Fruits and vegetables, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034.

Reports Description

Global Ready-to-Eat Food Market size is estimated at USD 428.80 Billion in 2025 and is expected to reach USD 546.08 Billion by 2034, at a CAGR of 5.14% during the forecast period.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=61876
DOI: 10.15468/dl.54mk97
title: Occurrence Download

description: A dataset containing 3171 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Culex sitiens Wiedemann, 1828"
 ]
}

 The dataset includes 3171 records from 29 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009715-250127130748423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.28331690.v1
title: Supplementary Material for: Concomitant Mosaic Turner Syndrome and Congenital Adrenal Hyperplasia in one of three patients of USP9X variant-associated Autism Spectrum Disorder

description: Abstract
Introduction: X-Linked Intellectual Developmental Disorder 99 (XLID99) is a rare neurodevelopmental disorder associated with mutations in the USP9X gene. This study reports on three patients diagnosed with autism spectrum disorder (ASD), highlighting novel genetic findings.
Case Presentation: Among the three patients, two male siblings exhibited a novel USP9X gene missense variant, while the third, a female, presented a unique deletion of the USP9X gene alongside adrenal insufficiency and mosaic Turner syndrome. This variant has not been reported in public databases and may influence ASD development.
Conclusion: This report documents the first instance of a triple diagnosis of XLID99, Turner syndrome, and congenital adrenal hyperplasia. Findings underline the significance of genetic evaluation in ASD for identifying rare and complex diagnoses.
DOI: 10.25946/28030874
title: Optimized Operation of Solar Powered Water Treatment Plants for Whitsunday Waters

description: A look at how to effectively utilize available resources and overall equipment investigation with the objective of optimizing electrical power usage thus promoting an efficiency focused perspective for Whitsunday’s Water Treatment Plant. With the ambition of attaining the goal of full electrical power self-sufficiency through solar and other electrical power generation methods that require research, thus relaxing demand within the regional electricity grid.
DOI: 10.6084/m9.figshare.26503551
title: Reactivation of nucleases with peroxidation damages induced by a menadione: ascorbate combination devastates human prostate carcinomas: ultrastructural aspects

description: Xenografts of androgen-independent human DU145 prostate metastatic carcinomas implanted in <i>nu/nu</i> male mice have revealed a significant survival after a prooxidant anticancer treatment consisting of a combination of menadione bisulfite and sodium ascorbate (VK3:VC). Implanted samples of diaphragm carcinomas from longest survived mice from either oral, intraperitoneal (IP), or both oral and IP treatment groups were assessed with light, scanning, and transmission electron microscopy to analyze morphologic damages. Compared with previous fine structure data of in vitro untreated carcinomas, the changes induced by oral, IP, and oral with IP VK3:VC treatment dismantled those xenografts with autoschizis, and necrotic atrophy was accomplished by cell’s oxidative stress whose injuries were consequent to reactivated deoxyribonucleases and ribonucleases. Tumor destructions resulted from irreversible damages of nucleus components, endoplasmic reticulum, and mitochondria there. Other alterations included those of the cytoskeleton that resulted in characteristic self-excisions named “ autoschizis.” All these injuries lead resilient cancer cells to necrotic cell death. The fine structure damages caused by VK3:VC prooxidant combination in the human DU145 prostate xenografts confirmed those shown in vitro and of other cell lines with histochemistry and biomolecular investigations. These devastations incurred without damage to normal tissues; thus, our data brought support for the above combination to assist in the treatment of prostate cancers and other cancers.
DOI: 10.6084/m9.figshare.26503551.v1
title: Reactivation of nucleases with peroxidation damages induced by a menadione: ascorbate combination devastates human prostate carcinomas: ultrastructural aspects

description: Xenografts of androgen-independent human DU145 prostate metastatic carcinomas implanted in <i>nu/nu</i> male mice have revealed a significant survival after a prooxidant anticancer treatment consisting of a combination of menadione bisulfite and sodium ascorbate (VK3:VC). Implanted samples of diaphragm carcinomas from longest survived mice from either oral, intraperitoneal (IP), or both oral and IP treatment groups were assessed with light, scanning, and transmission electron microscopy to analyze morphologic damages. Compared with previous fine structure data of in vitro untreated carcinomas, the changes induced by oral, IP, and oral with IP VK3:VC treatment dismantled those xenografts with autoschizis, and necrotic atrophy was accomplished by cell’s oxidative stress whose injuries were consequent to reactivated deoxyribonucleases and ribonucleases. Tumor destructions resulted from irreversible damages of nucleus components, endoplasmic reticulum, and mitochondria there. Other alterations included those of the cytoskeleton that resulted in characteristic self-excisions named “ autoschizis.” All these injuries lead resilient cancer cells to necrotic cell death. The fine structure damages caused by VK3:VC prooxidant combination in the human DU145 prostate xenografts confirmed those shown in vitro and of other cell lines with histochemistry and biomolecular investigations. These devastations incurred without damage to normal tissues; thus, our data brought support for the above combination to assist in the treatment of prostate cancers and other cancers.
DOI: 10.25946/28030874.v1
title: Optimized Operation of Solar Powered Water Treatment Plants for Whitsunday Waters

description: A look at how to effectively utilize available resources and overall equipment investigation with the objective of optimizing electrical power usage thus promoting an efficiency focused perspective for Whitsunday’s Water Treatment Plant. With the ambition of attaining the goal of full electrical power self-sufficiency through solar and other electrical power generation methods that require research, thus relaxing demand within the regional electricity grid.
DOI: 10.5281/zenodo.14184956
title: Label-free multiplexed detection of diabetic retinopathy biomarkers using fiber optic  biosensors: towards lab-in-the-tear

description: Raw experimental data on label-free detection of diabetic retinopathy biomarkers using fiber optic biosensors. This data contains information on the multiplexed and separate detection of LCN1 and VEGF diabetic retinopathy biomarkers in artificial tears.
DOI: 10.5281/zenodo.14184957
title: Label-free multiplexed detection of diabetic retinopathy biomarkers using fiber optic  biosensors: towards lab-in-the-tear

description: Raw experimental data on label-free detection of diabetic retinopathy biomarkers using fiber optic biosensors. This data contains information on the multiplexed and separate detection of LCN1 and VEGF diabetic retinopathy biomarkers in artificial tears.
DOI: 10.5281/zenodo.14187873
title: Label-free multiplexed detection of diabetic retinopathy biomarkers using fiber optic  biosensors: towards lab-in-the-tear

description: Raw experimental data on label-free detection of diabetic retinopathy biomarkers using fiber optic biosensors. This data contains information on the multiplexed and separate detection of LCN1 and VEGF diabetic retinopathy biomarkers in artificial tears.
DOI: 10.5281/zenodo.14190076
title: Label-free multiplexed detection of diabetic retinopathy biomarkers using fiber optic  biosensors: towards lab-in-the-tear

description: Raw experimental data on label-free detection of diabetic retinopathy biomarkers using fiber optic biosensors. This data contains information on the multiplexed and separate detection of LCN1 and VEGF diabetic retinopathy biomarkers in artificial tears.
DOI: 10.5281/zenodo.14791933
title: Label-free multiplexed detection of diabetic retinopathy biomarkers using fiber optic  biosensors: towards lab-in-the-tear

description: Raw experimental data on label-free detection of diabetic retinopathy biomarkers using fiber optic biosensors. This data contains information on the multiplexed and separate detection of LCN1 and VEGF diabetic retinopathy biomarkers in artificial tears.
DOI: 10.15468/dl.wfcss8
title: Occurrence Download

description: A dataset containing 280898 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((114.45059 -8.85633,115.74538 -8.85633,115.74538 -8.02309,114.45059 -8.02309,114.45059 -8.85633))",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 280898 records from 279 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009711-250127130748423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14791989
title: Europe Corporate Travel Market 2024 To 2033

description: Europe Corporate Travel Market Size, Trends and Insights By Type (Managed Business Travel, Unmanaged Business Travel), By Purpose (Marketing, Internal Meetings, Trade Shows, Product Launch, Others), By Expenditure (Travel Fare, Lodging, Dining, Others), By Age Group (Travelers Below 40 Years, Travelers Above 40 Years), By Traveller (Group Travel, Solo Travel), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the Europe Corporate Travel Market is expected to record a CAGR of 12.5% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 76.7 Billion. By 2033, the valuation is anticipated to reach USD 221.5 Billion.

The Europe Corporate Travel Market encompasses the provision of travel services and solutions tailored to meet the needs of businesses and corporate travelers across the European continent. It involves a wide range of services, including flight bookings, accommodation arrangements, ground transportation, and travel management services.

Key players in the market offering comprehensive solutions, leveraging technology, data analytics, and strategic partnerships to streamline travel processes, enhance traveler experience, and ensure cost-effective travel solutions.

The market is influenced by factors such as economic trends, technological advancements, regulatory requirements, and changing preferences of corporate travelers, driving continuous innovation and evolution within the industry.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=53593
DOI: 10.5281/zenodo.14791990
title: Europe Corporate Travel Market 2024 To 2033

description: Europe Corporate Travel Market Size, Trends and Insights By Type (Managed Business Travel, Unmanaged Business Travel), By Purpose (Marketing, Internal Meetings, Trade Shows, Product Launch, Others), By Expenditure (Travel Fare, Lodging, Dining, Others), By Age Group (Travelers Below 40 Years, Travelers Above 40 Years), By Traveller (Group Travel, Solo Travel), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the Europe Corporate Travel Market is expected to record a CAGR of 12.5% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 76.7 Billion. By 2033, the valuation is anticipated to reach USD 221.5 Billion.

The Europe Corporate Travel Market encompasses the provision of travel services and solutions tailored to meet the needs of businesses and corporate travelers across the European continent. It involves a wide range of services, including flight bookings, accommodation arrangements, ground transportation, and travel management services.

Key players in the market offering comprehensive solutions, leveraging technology, data analytics, and strategic partnerships to streamline travel processes, enhance traveler experience, and ensure cost-effective travel solutions.

The market is influenced by factors such as economic trends, technological advancements, regulatory requirements, and changing preferences of corporate travelers, driving continuous innovation and evolution within the industry.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=53593
DOI: 10.6084/m9.figshare.28331675
title: Dataset OMDT.xlsx

description: Abstract Background: Standard multi-drug therapy (MDT) with duration of 6-12 months is generally effective for treating leprosy. However, in cases of lepromatous (LL) and borderline lepromatous (BL) patients with high bacterial loads and complicated circumtances, prolonged duration treatment is more often observed. As prolonged duration may affect patient adherence negatively, adding ofloxacin to MDT is a promising approach to prevent prolonged treatment.. Method: This retrospective cohort study investigated the effects of adding ofloxacin to MDT in 21 patients diagnosed with LL or BL leprosy at Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia. Bacterial load and viability were tracked using the Bacteriological Index (BI) and Morphological Index (MI), and were compared using non-parametric Friedman test before and after the patients were given ofloxacin. Findings: Adding ofloxacin to MDT led to a significant reductions in both BI and MI. The median MI dropped to zero after six months of combined treatment (p&lt;0.001), with significant differences between baseline and 6, 9, and 12-months. BI also significantly declined (p=0.007), with significant reductions between baseline and 3, 6, 9, and 12-month assessments. The proportion of patients reaching an MI of zero also steadily increased. Interpretation: Ofloxacin as an adjunctive therapy to MDT substantially improves treatment of leprosy with high bacterial and morphological index. Faster bacterial clearance prevent prolonged treatment duration, potentially improving adherence, outcomes and reducing relapse risk. Ofloxacin is the only second-line leprosy treatment covered by the national health insurance in Indonesia. Earlier initiation of this adjunctive therapy may offer greater benefits.
DOI: 10.15468/dl.3s4mdd
title: Occurrence Download

description: A dataset containing 19995 species occurrences available in GBIF matching the query:
{
 "and" : [
 "License is one of (CC0 1.0, CC-BY 4.0)",
 "TaxonKey is Cyperus rotundus L."
 ]
}

 The dataset includes 19995 records from 626 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009718-250127130748423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.m6teu6
title: Occurrence Download

description: A dataset containing 16 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cordylostigma microcala (Bremek.) Groeninckx & Dessein"
 ]
}

 The dataset includes 16 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0145502-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.znb9pk
title: Occurrence Download

description: A dataset containing 2774 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Salvia officinalis L."
 ]
}

 The dataset includes 2774 records from 215 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0004241-150922153815467/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.kv9kss
title: Occurrence Download

description: A dataset containing 1002 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cordylostigma virgatum (Willd.) Groeninckx & Dessein"
 ]
}

 The dataset includes 1002 records from 62 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0145514-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.gjgmt7
title: Occurrence Download

description: A dataset containing 684 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Schotia brachypetala Sond."
 ]
}

 The dataset includes 684 records from 44 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0004241-151016162008034/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.5p2qpx
title: Occurrence Download

description: A dataset containing 193 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Coreopsis latifolia Michx."
 ]
}

 The dataset includes 193 records from 29 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0145632-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dpfkzb
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Scatimus Erichson, 1847",
 "Country is Brazil"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0004241-160526112335914/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.rrf57u
title: Occurrence Download

description: A dataset containing 1346 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Coreopsis maritima (Nutt.) Hook.fil."
 ]
}

 The dataset includes 1346 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0145644-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.py8s5j
title: Occurrence Download

description: A dataset containing 515 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Mexico",
 "TaxonKey is Ambystoma mexicanum (Shaw & Nodder, 1798)"
 ]
}

 The dataset includes 515 records from 33 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0032749-231002084531237/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.i0bct5
title: Occurrence Download

description: A dataset containing 196 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Solanum forskalii Dunal"
 ]
}

 The dataset includes 196 records from 23 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0004241-160910150852091/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.nqkvfc
title: Occurrence Download

description: A dataset containing 23 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Mustela strigidorsa Gray, 1853"
 ]
}

 The dataset includes 23 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0026753-231002084531237/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qjfmun
title: Occurrence Download

description: A dataset containing 436 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bromus brachyantherus Döll"
 ]
}

 The dataset includes 436 records from 47 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0004241-170627171947987/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.x4dx2s
title: Occurrence Download

description: A dataset containing 1008 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Viverra zibetha Linnaeus, 1758"
 ]
}

 The dataset includes 1008 records from 43 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0026779-231002084531237/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.